The IPO market in India is once again heating up. As November 2025 kicks off, retail and institutional investors alike are gearing up for another exciting line-up. But with multiple new issues opening between November 1 and November 15, 2025, a critical question looms — Which IPOs are truly worth your bid?

From established consumer names to fast-growing tech and FMCG players, this fortnight’s IPO calendar offers something for every type of investor. However, not all IPOs are created equal. A few show short-term listing gain potential, while others shine in their long-term earnings power.

Let’s break down the Best IPO and GMP trends for November 2025, company by company — and see who’s really delivering value.

• Sector: Eyewear Retail / D2C Consumer

• Price Band: ₹382–₹402

• Issue Size: ₹7,278 crore

• Lot Size: ~37 shares

• Open/Close: Oct 31–Nov 4, 2025

• Listing Date: Nov 10, 2025

• Promoter Holding: Founders + PE-backed (SoftBank, Kedaara Capital)

The much-awaited Lenskart Solutions IPO has already captured investor attention. With global backers like SoftBank and the Damani group, this direct-to-consumer eyewear brand is one of the largest listings of the year.

Its Grey Market Premium (GMP) of ₹119, translating to nearly 29.6%, makes it the top short-term contender among November’s offerings. Beyond momentum, its fundamentals are robust — multi-year revenue growth above 35% CAGR, EBIT margins around 14%, and an asset-light model that drives scalability.

Lenskart’s numbers put it firmly in the top 5 percentile of its retail peers, with earnings and return ratios that could justify its valuation. If you’re looking for both listing gains and long-term sector leadership, this one might check the boxes

 Note of Caution: A large part of this year’s reported profit comes from one-time other income — raising the question of how much real upside remains for investors.

• Sector: FMCG (foods & home brands)

• Price Band: ₹695–₹730

• Issue Size: ₹1,667.5 crore

• Lot Size: 20 shares

• Open/Close: Oct 29–31, 2025

• Listing Date: Nov 6, 2025

Orkla India, the consumer-focused arm of a reputed multinational, combines strong brand equity with predictable growth. Its GMP of ₹106 (≈ 14.5%) places it just below the quick-gain benchmark, but its fundamentals — high margins, strong ROE/ROCE, and diversified product portfolio — give it staying power.

Compared with peers like Britannia and Nestlé, Orkla stands comfortably in the top third of the FMCG sector in EBIT margin and earnings quality.

This one appeals to investors seeking stability and long-term compounding potential rather than overnight excitement.

• Sector: Auto Components (helmets & accessories)

• Price Band: ₹557–₹585

• Issue Size: ₹455.5 crore

• Lot Size: 25 shares

• Open/Close: Oct 30–Nov 3, 2025

• Listing Date: Nov 7, 2025

Studds Accessories, India’s leading helmet maker, offers consistent revenue and profitability but lacks the short-term buzz of its peers. With a GMP around 9.9%, listing gains appear limited. Margins are stable but not sector-leading, and investor enthusiasm has been mixed. It remains a sound business — just not among the Best IPO and GMP plays of the month.

The SME corner adds two smaller listings — Shreeji Global FMCG and Jayesh Logistics. Data transparency and limited financial disclosures make these harder to evaluate. Shreeji’s GMP data is unavailable, while Jayesh Logistics shows modest demand and a 4% GMP. Both warrant a wait-and-watch stance rather than aggressive bidding.

The Verdict – November’s Best IPO and GMP Ranking

When you weigh fundamentals, GMP strength, and sector positioning, only a few stand out as clear winners. Here’s how the numbers stack up:

Source: Moneycontrol, Economic Times, The Ipo List (as of Oct 28 2025). GMP = Grey Market Premium.

📊 Source: Moneycontrol, Economic Times, The IPO List (as of Oct 28, 2025). GMP = Grey Market Premium.

📊 Source: Moneycontrol, Economic Times, The IPO List (as of Oct 28, 2025). GMP = Grey Market Premium.

Among all IPOs between Nov 1 – 15 2025, Lenskart Solutions leads both for listing gains and long-term potential if you are ok with the valuations, with Orkla India a close second for steady compounding. Others like Studds Accessories can be held selectively, while SME listings warrant more caution.

The bottom line: November’s Best IPO and GMP list belongs to Lenskart for its growth story and to Orkla for its sector resilience — proving once again that both momentum and fundamentals matter.

Which IPOs are you eyeing this week — Lenskart Solutions, Orkla India, or one of the upcoming mid-November listings? Will you place your bids early or wait to see how the GMP trends and subscription numbers evolve?

💬 Share your picks in the comments — we’d love to hear which IPOs you’re backing and your strategy for November’s line-up.

📩 Write to us at info@wiremeshin.comor subscribe here to join our growing community of informed investors.

Take the first step in Giving Wings to Your Financial Dreams

Greetings, I’m Sanil — Founder of Wiremesh.

I started Wiremesh in 2010 to bring practical, insightful, and personalized financial advice to individuals and businesses. In 2018, Silicon India Magazine recognized our work by naming Wiremesh among the 10 Most Promising Investment Planning Companies.

Before founding Wiremesh, I worked with global BFSI leaders like HSBC and Barclays, where I led key business verticals and helped create substantial wealth across diverse portfolios.

Subscribe here to ‘Stay Informed With Sanil.’ If you’re looking for expert-level market insights, smart investing strategies, and actionable financial tips—this is for you.

🔹 Thoughtful market commentary

🔹 Stock and sector insights

🔹 Strategic investment ideas

🔹 Real-world wealth-building guidance

Let’s turn your financial aspirations into action.

This article is for informational purposes only and does not constitute investment advice. Investing in shares carries significant risk, including loss of capital, illiquidity, and valuation uncertainty. Readers are strongly encouraged to consult a SEBI-registered financial adviser before making any investment decisions. The information provided is based on publicly available data and sources believed to be reliable as of the date indicated, but may change without notice.

Open an Investment DMAT A/C catering to Mutual Funds, Stocks, Gold Bonds, NPS, and much more in easy steps